SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-008026
Filing Date
2015-02-11
Accepted
2015-02-11 17:29:37
Documents
1
Group Members
FORESITE CAPITAL MANAGEMENT II, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G v401084_sc13g.htm SC 13G 70817
  Complete submission text file 0001144204-15-008026.txt   72606
Mailing Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111
Business Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund II, L.P. (Filed by) CIK: 0001594914 (see all company filings)

IRS No.: 901029166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Subject) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-88634 | Film No.: 15600666
SIC: 2834 Pharmaceutical Preparations